abstract |
(57) Abstract: The present invention relates to a novel carbamate oxadiazolone derivative having the following general formula or a non-toxic pharmaceutically acceptable salt thereof, which is effective for treating diseases responsive to high conductance calcium activity or potassium channel opening. Pertaining to acceptable salts or solvates; Wherein R 1 and R 2 are as defined in the description. |